H.B. Fuller Company entered into an amendment to its Second Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. on July 17, 2026. The amendment refinanced $420,000,000 in Term A loans and $700,000,000 in revolving loans, while increasing the total revolving credit facility to $800,000,000. The maturity date for these facilities was extended to July 17, 2031, and interest rate margins were reduced by 25 basis points. Concurrently, the company terminated a previously established $2,086,713,188 Secured Bridge Credit Agreement with Goldman Sachs Bank USA, which had no outstanding loans at termination. H.B. Fuller Company is a specialty chemicals manufacturer.

H.B. Fuller Company announced a recommended cash offer by its subsidiary, H.B. Fuller Medical Adhesive Technologies Inc., to acquire the entire share capital of Advanced Medical Solutions Group plc (AMS) for 285 pence per share. To finance the transaction, the company entered into bridge credit agreements with Goldman Sachs Bank USA for up to $2,086,713,188 in secured borrowings and $917,000,000 in unsecured borrowings. The transaction is expected to be completed by the end of 2026, subject to regulatory and shareholder approvals. H.B. Fuller Company is a manufacturer of specialty chemicals and adhesives.

H.B. Fuller Company announced its operating results for the second quarter ended May 29, 2026. The company is in the specialty chemicals industry and provides adhesives, sealants, and other specialty chemical products.